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Abstract
Tissue hypoxia is a common end product of circulatory shock and a
primary target for resuscitation efforts. In this issue Podbregar and
Mozina show that thenar tissue O2 saturation (StO2) and mixed
venous O2 saturation (SvO2) co-vary in patients in left ventricular
failure, but in patients with sepsis StO2 was higher than SvO2.
Although StO2 may co-vary with SvO2 they have different deter-
minants such that after shock StO2 may increase well before SvO2
as a result of increased O2 demands to repay O2 debt incurred
during hypoperfusion. Thus, the use of StO2 alone to define the
endpoint of resuscitation may be misleading.
In this issue of the journal Podbregar and Mozina propose the
use of tissue oxygen saturation (StO2), monitored non-
invasively with near-infrared spectroscopy of the thenar
muscle, as a surrogate measurement of tissue perfusion [1].
They measured StO2 in patients with left ventricular (LV)
failure and with or without sepsis. They reasoned that StO2
would discriminate between patients with low cardiac output
and preserved or unimpaired O2 extraction ratio (not present
in septic patients) from those septic patients with poor
ventricular function and low O2 extraction ratio as assessed
by SvO2 [1]. Not unexpectedly, they found the lowest StO2
values in patients with LV failure without sepsis. Interestingly,
StO2 was significantly higher in patients with both LV failure
and sepsis than in normal volunteers. Unfortunately, the
authors did not address the fundamental differences between
peripheral StO2 and SvO2 even though they suggest that
StO2 may replace SvO2 in the absence of sepsis. These
issues deserve comment.
Severe shock is characterized by inadequate O2 delivery
relative to metabolic demands [2]. Unfortunately, present
monitoring techniques for the assessment of O2 delivery and
O2 utilization are invasive, impracticable, give an incomplete
picture of the circulation, and may not be useful in guiding
effective resuscitation, as documented by the poorer
outcomes for SvO2-guided therapy in patients with
established shock [3,4]. Recently, however, early goal-
directed  therapy in patients with sepsis presenting to an
emergency department improves outcome when central
venous O2 saturation is used as one of the endpoints of
resuscitation [5]. Still, neither SvO2 nor central venous O2
provide any insight on the state of oxygen utilization in tissues.
The relationship between StO2 and SvO2 is not always
predictable. Although StO2 should decrease when tissues
are starved of O2 relative to their needs, the physiological
events dictating changes in StO2 and SvO2 are different.
Ischemic tissues initially sustain metabolism by anaerobic
respiration, leading to an ‘O2 debt’ shown by a transient
increase in O2 consumption during reoxygenation. Similarly,
StO2 must increase before SvO2 increases because its
increase is the cause of the increase in SvO2. SvO2 may
therefore remain low for a while despite normalization of
StO2. Thus, with decreases in O2 delivery one would expect
both SvO2 and StO2 to decrease in parallel, but with
resuscitation StO2 should increase before SvO2..
Shock is a complex process with neurovascular, metabolic
and inflammatory responses occurring simultaneously.
Changes in StO2 capture the vasoconstriction associated
with reduced cardiac output during progressive hypovolemia.
In fact, StO2 is as good a predictor of multiple organ
dysfunction syndrome in trauma patients as base deficit, with
the advantage that StO2 is continuous and noninvasive [6].
Initially, the O2 extraction ratio in hemorrhagic shock is high,
and cellular metabolism is not compromised. However, as
flow decreases, extremity flow usually decreases first;
therefore decreases in thenar StO2 should occur before
significant visceral ischemia develops, and when thenar StO2
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has recovered after resuscitation most other organs should
also show resolution of ischemia. Unfortunately, when shock
progresses to generalized mitochondial dysfunction, tissue
wellness will not be captured by StO2 values alone. Therefore
an ideal noninvasive monitoring platform for shock should
indicate not only that O2 delivery is impaired but also the
extent to which this has affected cell metabolism. Such
parameters may include tissue pH, partial pressure of CO2,
and ideally the levels of a mitochondrial function product such
as NADH. Furthermore, many of these changes are dynamic
and multidirectional depending on the integrity of the
patient’s compensatory response and the timeliness and
effectiveness of the resuscitation.
It is necessary to understand the hysteresis of the StO2
response throughout the continuum of shock and resusci-
tation. Such information is lacking in the report by Podbregar
and Mozina. However, a physiologic perturbation such as
inducing a brief episode of forearm ischemia as a circulatory
stress test, to note the rapidity of re-oxygenation upon
release, may be more revealing about the physiologic reserve
of the patient and the metabolic activity of the muscle. We
have used this approach in a fashion similar to that of De
Blasi and colleagues [7]. Our preliminary study [8] supports
previously published findings that resting StO2 levels in both
normal volunteers and patients with sustained circulatory
shock are not dissimilar and thus cannot be used for early
monitoring of tissue hypoperfusion [9]. However, by inducing
an occlusion stress, emergent parameters can be defined
that allow one to assess local metabolic demand and reper-
fusion reserve. Potentially, this approach might prove useful in
clinical decision making. We are still searching for measures
of circulatory adequacy, and non-invasive measures of StO2
reflect one exciting avenue of exploration. Let us use it to
define the adequacy of resuscitation therapy in those in
circulatory shock. Whether its value may or may not track
SvO2 is less of an issue than its potential to define circulatory
sufficiency.
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